Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

0.524
Delayed Data
As of 10:50am ET
 -0.001 / -0.19%
Today’s Change
0.44
Today|||52-Week Range
3.72
-41.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues854.0K683.0K670.0K640.0K
 
 
 
 
 
Depreciation And Amortization11.0K2.0K3.0K3.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.5M9.3M12.0M10.5M
 
 
 
 
 
Research And Development6.3M5.3M7.6M6.2M
 
 
 
 
 
Total Operating Expenses11.5M9.3M12.0M10.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.6M-8.6M-11.3M-9.9M
 
 
 
 
 
Extraordinary Charge-1.7M-5.3M0.000.00
 
 
 
Interest Expense On Debt233.0K233.0K234.0K298.0K
 
 
 
 
 
Other Expenses3.6M7.1M-4.0K76.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.9M-7.0M-11.6M-10.1M
 
 
 
 
 
Net Income-8.9M-7.0M-11.6M-10.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.5M74.8M76.7M86.7M
 
 
 
 
 
Shares To Calculate EPS Diluted72.5M74.8M76.7M86.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.09-$0.15-$0.12
 
 
 
 
 
EPS Diluted-$0.15-$0.09-$0.15-$0.12